Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)
New Zealand · Delayed Price · Currency is NZD 44.39
+0.20 (0.45%)
Sep 17, 2026, 5:00 PM NZST
NZE:FPH Cash Flow Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 468.5 | 377.2 | 132.6 | 250.3 | 376.9 |
Depreciation & Amortization | 149.4 | 133.8 | 109.1 | 93.9 | 86.7 |
Other Amortization | 9.2 | 6.1 | 5.2 | 5.1 | 9.3 |
Asset Writedown & Restructuring Costs | - | - | 98.1 | - | - |
Stock-Based Compensation | 13.9 | 11.2 | 10.8 | 9 | 8.1 |
Other Operating Activities | 6.2 | 27.2 | 61.5 | -50.9 | -115.2 |
Change in Accounts Receivable | -28.4 | -45.1 | -38.5 | -43.3 | 52.5 |
Change in Inventory | 15.5 | -22.5 | 45.4 | -6.9 | -88.3 |
Change in Accounts Payable | 28.9 | 60.7 | 5.4 | -19 | -5.7 |
Operating Cash Flow | 663.2 | 548.6 | 429.6 | 238.2 | 324.3 |
Operating Cash Flow Growth | 20.89% | 27.70% | 80.35% | -26.55% | -48.14% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -172.8 | -73.6 | -316.8 | -187.8 | -138.4 |
Sale (Purchase) of Intangibles | -22.4 | -29.4 | -22.2 | -23.5 | -31.4 |
Investment in Securities | - | - | - | 200 | 80.3 |
Investing Cash Flow | -195.2 | -103 | -339 | -11.3 | -89.5 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 52.5 | 106.8 | 300.6 | 137.5 | 7.5 |
Long-Term Debt Repaid | -81.1 | -182.2 | -286.8 | -141.9 | -21.6 |
Lease Payments | -21.4 | -18.5 | -16.8 | -14.4 | -14 |
Net Debt Issued (Repaid) | -28.6 | -75.4 | 13.8 | -4.4 | -14.1 |
Issuance of Common Stock | 4.2 | 3.1 | 3 | 3 | 3.2 |
Common Dividends Paid | -223.9 | -168.2 | -119.3 | -171 | -200.5 |
Financing Cash Flow | -276.7 | -268.2 | -128.7 | -197.1 | -235.8 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | 2.3 | 1.9 | 2.2 | 2.4 | 0.2 |
Net Cash Flow | 193.6 | 179.3 | -35.9 | 32.2 | -0.8 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 490.4 | 475 | 112.8 | 50.4 | 185.9 |
Free Cash Flow Growth | 3.24% | 321.10% | 123.81% | -72.89% | -60.03% |
Free Cash Flow Margin | 21.24% | 23.50% | 6.47% | 3.19% | 11.05% |
Free Cash Flow Per Share | 0.83 | 0.81 | 0.19 | 0.09 | 0.32 |
Levered Free Cash Flow | 399.41 | 436.86 | 45.7 | 26.94 | 78.24 |
Unlevered Free Cash Flow | 405.85 | 443.8 | 57.08 | 31.13 | 81.3 |
Free Cash Flow After Leases | 469 | 456.5 | 96 | 36 | 171.9 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 10.7 | 13.4 | 19.9 | 9 | 4.8 |
Cash Income Tax Paid | 161.4 | 90.4 | 51.8 | 121.2 | 249.7 |
Change in Working Capital | 16 | -6.9 | 12.3 | -69.2 | -41.5 |